How common is severe pulmonary hypertension after pediatric cardiac surgery?

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 6, 2002, Pages 1155-1163

  Lindberg, L ^a   Olsson, A K ^a   Jogi P ^a   Jonmarker, C ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CHILD; DOWN SYNDROME; FALLOT TETRALOGY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INCIDENCE; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0036621698     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.121497     Document Type: Article

References (26)

1. Hoffman JI, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation. 1981;64:873-7.
2. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 1993;87:440-6.
3. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-38.
4. Kameyama T, Ando F, Okamoto F, Hanada M, Yamanaka K, Sasahashi N, et al. The effect of modified ultrafiltration in pediatric open heart surgery. Ann Thorac Surg. 2000;6:19-26.
5. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg. 1994;107:1129-35.
6. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet. 2000;356:1464-9.
7. Jenkins KJ, Newburger J, Lock JE, Davis RB, Coffman GA, Iezzoni LI. In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics. 1995;95:323-30.
8. Örtendahl C, Karlberg I. The organization of the pediatric cardiac surgery in Sweden: recommendation from the Swedish National Board of Health and Welfare [Swedish]. Stockholm; Socialstyrelsen: 1992;3.
9. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg. 1996;112:1600-7.
10. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg. 1995;60:1765-71.
11. Goldman AP, Delius RE, Deanfield JE, de Leval MR, Sigston PE, Macrae DJ. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension. Ann Thorac Surg. 1996;62:750-5.
12. Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg. 1991;5:628-34.
13. Lundstrom NR, Berggren H, Bjorkhem G, Jögi P, Sunnegårdh J. Centralization of pediatric heart surgery in Sweden. Pediatr Cardiol. 2000;21:353-7.
14. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg. 1993;106:473-8.
15. Yoshibayashi M, Nishioka K, Nakao Y. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart disease. Circulation. 1991;84:2280-5.
16. Svenmarker S, Sandström E, Karlsson T, Jansson E, Häggmark S, Lindholm R, et al. Clinical effects of the heparin coated surface in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1997;11:957-64.
17. Velthuis H, Jansen P, Hack E, Eijsman L, Wildevuur C. Specific complement inhibition with heparin-coated extracorporeal circuits. Ann Thorac Surg. 1996;61:1156-7.
18. Lodge AJ, Chai PJ, Daggett CW, Ungerleider RM, Jaggers J. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg. 1999;117:515-22.
19. Bando K, Turrentine MW, Vijay P, Sharp TG, Sekine Y, Lalone BJ, et al. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg. 1998;66: 821-7.
20. Jacobs IN, Gray RF, Todd NW. Upper airway obstruction in children with Down syndrome. Arch Otolaryngol Head Neck Surg. 1996;122: 945-50.
21. Lefaivre JF, Cohen SR, Burstein FD, Simms C, Scott PH, Montgomery GL, et al. Down syndrome: identification and surgical management of obstructive sleep apnea. Plast Reconstr Surg. 1997;99:629-37.
22. Tweddell J, Litwin S, Berger S, Friedberg D, Thomas J, Frommelt P, et al. Twenty-year experience with repair of complete atrioventricular septal defects. Ann Thorac Surg. 1996;62:419-24.
23. Hanley FL, Fenton KN, Jonas RA, Mayer JE, Cook NR, Wernovsky G, et al. Surgical repair of complete atrioventricular canal defects in infancy. J Thorac Cardiovasc Surg. 1993;106:387-97.
24. Chi TL. The pulmonary vascular bed in children with Down syndrome. J Pediatr. 1975;86:533-8.
25. Yamaki S, Yasui H, Kado H, Yonenaga K, Nakamura Y, Kikuchi T, et al. Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy. J Thorac Cardiovasc Surg. 1993;106:398-405.
26. Reller MD, Morris CD. Is Down syndrome a risk factor for poor outcome after repair of congenital heart defects? J Pediatr. 1998;132:738-41.